Senator Warren urged the US Patent and Trademark Office to carefully review Merck's Keytruda

Published Date: 02 Mar 2023

U.S. Senator Elizabeth Warren has sent a letter to the nation's leading patent attorney asking for further review of Merck's new patent application for its cancer drug Keytruda, which seeks to block the drug. , he said.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

New policy review highlights the importance of health-related quality of life in advanced cancer

2.

'Personalized' Approach to RT for Bladder Cancer Promising but Challenging

3.

CAR-T Trial Raises Prospect of Preventing Myeloma in High-Risk Group

4.

Early Tislelizumab May Boost PFS in Esophageal Cancer

5.

No PFS Benefit With Immune Checkpoint Inhibitor Rechallenge in Renal Cell Carcinoma


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot